Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR) Receives $51 25 Consensus Price Target from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has been given a consensus rating of “Moderate Buy” by the fifteen research firms that are covering the firm, MarketBeat reports. Five investment analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12-month price target […]
Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) have received an average recommendation of “Moderate Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12 month target price […]
Research analysts at Bank of America began coverage on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) in a research report issued on Monday, Briefing.com reports. The firm set a “buy” rating and a $29.00 price target on the biotechnology company’s stock. Bank of America‘s target price suggests a potential upside of 25.16% from […]
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) had its price target dropped by Morgan Stanley from $40.00 to $37.00 in a report released on Thursday, Benzinga reports. The firm presently has an “equal weight” rating on the biotechnology company’s stock. Morgan Stanley’s target price would indicate a potential upside of 43.91% from the stock’s previous […]